Stopping or reporting early for positive results in randomized clinical trials: the National Cancer Institute Cooperative Group experience from 1990 to 2005.
about
Rosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspectiveEndovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis.Rosuvastatin for primary prevention in older persons with elevated C-reactive protein and low to average low-density lipoprotein cholesterol levels: exploratory analysis of a randomized trial.Bioethics in Practice: Considerations for Stopping a Clinical Trial Early.Prematurely ended phase III trials in Sweden during the years 2002-2008.Stopping trials early for benefit--not so fast!Quantifying over-estimation in early stopped clinical trials and the "freezing effect" on subsequent research.Publishing interim results of randomised clinical trials in peer-reviewed journals.BRIM-1, -2 and -3 trials: improved survival with vemurafenib in metastatic melanoma patients with a BRAF(V600E) mutation.How to interpret a randomized controlled study stopped early.Adjuvant trastuzumab for breast cancer: uncertainties in clinical and economic evidence following early stopping of the HERA trial.Analgecine, the extracts of Vaccinia-inoculated rabbit skin, effectively alleviates the chronic low back pain with little side effect - A randomized multi-center double-blind placebo-controlled phase 3 clinical trial.
P2860
Q24594814-31F923CE-C69A-42A3-B42C-B227E667971DQ26752659-71F5A55B-6CEB-4350-A747-180FA9B278A0Q34158442-C8B66F14-4E24-4DFE-96AF-BF7C830CE333Q37258988-68FC709F-D09A-4165-BC36-FA151BF89DC0Q37852595-F10C4777-B048-4E83-AD18-43FB3F44DB87Q38058499-C030760A-E58E-446C-AB3C-771147AC72D1Q38856986-D8FB1DA9-CE31-42DD-A086-0C32F7C9862BQ39021028-9125B8A3-1C76-4053-A7A8-2ACB6AD50A7AQ39610538-226E5BB8-F5CC-43D9-9AE5-B6624AE279D6Q44051921-D79551E3-F664-4112-A605-4E5EF311B82EQ46431617-C0E755A8-C74C-473E-9013-4563499EB747Q55332999-314F325A-28CE-4D84-B5DD-6C0CD317701A
P2860
Stopping or reporting early for positive results in randomized clinical trials: the National Cancer Institute Cooperative Group experience from 1990 to 2005.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Stopping or reporting early fo ...... experience from 1990 to 2005.
@en
Stopping or reporting early fo ...... experience from 1990 to 2005.
@nl
type
label
Stopping or reporting early fo ...... experience from 1990 to 2005.
@en
Stopping or reporting early fo ...... experience from 1990 to 2005.
@nl
prefLabel
Stopping or reporting early fo ...... experience from 1990 to 2005.
@en
Stopping or reporting early fo ...... experience from 1990 to 2005.
@nl
P2860
P356
P1476
Stopping or reporting early fo ...... experience from 1990 to 2005.
@en
P2093
Edward L Korn
Margaret Mooney
P2860
P304
P356
10.1200/JCO.2008.19.5339
P407
P577
2009-02-23T00:00:00Z